• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - COSTA RICA (COYOL) ALAIR¿; BRONCHIAL THERMOPLASTY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - COSTA RICA (COYOL) ALAIR¿; BRONCHIAL THERMOPLASTY SYSTEM Back to Search Results
Model Number M005ATS25010
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Unspecified Infection (1930)
Event Date 05/28/2018
Event Type  Injury  
Manufacturer Narrative
The complainant was unable to provide the suspect device lot number; therefore, the lot expiration and device manufacture dates are unknown.However, the complainant reported that the device was not expired.(b)(6).The complainant indicated that the device will not be returned for evaluation; therefore a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Event Description
It was reported to boston scientific corporation that an alair bronchial thermoplasty (bt) catheter was used during a bronchial thermoplasty procedure performed as part of the (b)(6) study.On (b)(6) 2018 the patient was admitted to the hospital as planned for the bt treatment.On (b)(6) 2018 the patient underwent the first bronchial thermoplasty treatment in the right lower lobe of the lungs.No issues were noted with the device.The patient was discharged from the hospital on (b)(6) 2018.According to the complainant, on (b)(6) 2018 the patient experienced lower respiratory tract infection and pleurisy.The patient was hospitalized from (b)(6) 2018 due to this event.The patient had a drainage tube placed from (b)(6) 2018.The patent was administered antibiotic (sulbactam sodium ampicillin sodium)9g/day from (b)(6) 2018.The patient was also administered antibiotic (oral) potassium clavulanate 3 tablets per day from (b)(6) 2018 to (b)(6) 2018.The patient was also administered amoxicillin hydrate 750mg/day from (b)(6) 2018 to (b)(6) 2018.The event has resolved and the patient was discharged without any further issues reported.
 
Event Description
It was reported to boston scientific corporation that an alair bronchial thermoplasty (bt) catheter was used during a bronchial thermoplasty procedure performed as part of the e7088 alair japan pms clinical study.On (b)(6) 2018 the patient was admitted to the hospital as planned for the bt treatment.On (b)(6) 2018 the patient underwent the first bronchial thermoplasty treatment in the right lower lobe of the lungs.No issues were noted with the device.The patient was discharged from the hospital on (b)(6) 2018.According to the complainant, on (b)(6) 2018 the patient experienced lower respiratory tract infection and pleurisy.The patient was hospitalized from (b)(6) 2018 to (b)(6) 2018 due to this event.The patient had a drainage tube placed from (b)(6) 2018 to (b)(6) 2018.The patent was administered antibiotic (sulbactam sodium ampicillin sodium)9g/day from (b)(6) 2018 to (b)(6) 2018.The patient was also administered antibiotic (oral) potassium clavulanate 3 tablets per day from (b)(6) 2018 to (b)(6) 2018.The patient was also administered amoxicillin hydrate 750mg/day from (b)(6) 2018 to (b)(6) 2018.The event has resolved and the patient was discharged without any further issues reported.Additional information received on 15aug2018.On (b)(6) 2018 the patient recovered from the lower respiratory tract infection and pleurisy.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALAIR¿
Type of Device
BRONCHIAL THERMOPLASTY SYSTEM
Manufacturer (Section D)
BOSTON SCIENTIFIC - COSTA RICA (COYOL)
2546 first street
propark free zone
alajuela
CS 
MDR Report Key7679635
MDR Text Key113737594
Report Number3005099803-2018-02097
Device Sequence Number1
Product Code OOY
UDI-Device Identifier08714729802792
UDI-Public08714729802792
Combination Product (y/n)N
PMA/PMN Number
P080032
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 06/12/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberM005ATS25010
Device Catalogue NumberATS 2-5
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 06/12/2018
Initial Date FDA Received07/11/2018
Supplement Dates Manufacturer Received08/15/2018
Supplement Dates FDA Received08/29/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age66 YR
Patient Weight41
-
-